coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Wigan Central PCN, Wigan (LAD) · Health Inequalities Profile

    PCN U42152 · NHS Greater Manchester Integrated Care Board · 9 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    62,862

    Registered population

    61.0% aged 18–64

    18.9%

    Aged 65+

    ICB 14.9% · England 17.9%

    42.3%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~25,244

    Core20 residents (est.)

    Resident basis; registered basis ~26,849 · see page 3

    12,050

    Hypertension register

    +12.67% in 3 yrs · England +5.60%

    783

    SMI register

    21.9% of Wigan (LAD)'s

    1,758

    COPD register

    Reviews +5.51% in 3 yrs

    Forecast to 2030

    15,604

    Hypertension patients, 2030

    +3,554 on today

    61.5%

    QRISK ≥20% on statins, 2030

    -0.41pp over 3 yrs

    5.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    77.1%
    Hypertension treatment to target exceeds national benchmark.

    Across 12,050 registered hypertension patients, 77.1% are treated to target against 75.6% in Wigan (LAD), 71.4% in the ICB and 70.3% in England.

    61.9%
    Asthma review coverage trails England and ICB.

    Annual asthma review coverage is 61.9% (England 65.7%, ICB 66.2%), leaving an estimated scale of 1,653 of 4,339 register patients without a review.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults make up 18.9% of the list alongside 891 care home beds

    Across 62,862 registered patients, 18.9% are aged 65+ (11,875 patients), above Wigan (LAD) (18.8%), NHS Greater Manchester Integrated Care Board (14.9%) and England (17.9%). Children aged 0–17 make up 20.2% (12,670; LAD 20.0%, ICB 21.8%, England 19.6%) and adults aged 18–64 form 61.0% (38,317; LAD 61.6%, ICB 63.3%, England 62.7%). Projected population growth to 2030 is 1.0% (LAD 1.1%, ICB 1.6%, England 2.3%), using unverified methods. Census resident data records Gypsy or Irish Traveller and Roma groups each at 0.1% (LAD 0.1%, ICB 0.1%, England 0.1% and 0.2%). The catchment includes 24 care homes with 891 beds.

    Age profile

    0–1720.2%
    18–6461.0%
    65+18.9%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Wigan (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wigan LA)2,7062,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)86.0%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.5%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wigan LA)1,2431,0219552024/25
    Falls deaths, all ages, per 100,000 (Wigan LA)12.318.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 42.3% and spans 75.0 percentage points across practices

    Across Wigan Central PCN, 42.3% of registered patients live in Core20 areas, above England (21.0%) and Wigan (LAD) (29.4%), with an average IMD decile of 4.0. Practice shares span 75.0 pp, from 11.4% at Dr Seabrook to 86.4% at Marsh Green Medical Practice. Pemberton Surgery holds the highest volume at 5,707 estimated Core20 patients. Practice estimates sum to 26,849, compared with 25,244 estimated Core20 residents. Targeting requires balancing intensive neighbourhood outreach at high-concentration practices with clinical capacity at high-volume sites.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Marsh Green86.4% · 3,868 patients
    Pemberton56.0% · 5,707 patients
    Newtown Medical52.5% · 3,182 patients
    Dicconson42.5% · 4,037 patients
    Longshoot Medical42.4% · 3,038 patients
    Sullivan Way41.5% · 3,239 patients
    Bradshaw28.6% · 2,497 patients
    Mesnes View16.9% · 806 patients
    Dr Seabrook11.4% · 475 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    783

    SMI register

    1.22% recorded prevalence

    482

    Learning disability register

    0.75% recorded prevalence

    24

    Care homes, 891 beds

    In the PCN catchment

    10.1%

    Provide unpaid care

    Wigan (LAD), Census 2021

    Severe mental illness prevalence is 1.2% (783 patients), above Wigan (LAD) (1.0%), NHS Greater Manchester Integrated Care Board (1.1%) and England (1.0%). Learning disability prevalence is 0.8% (482 patients; LAD 0.7%, ICB 0.6%, England 0.6%). These crude recorded register rates do not establish undiagnosed disease, under-detection or unmet need.

    Severe mental illness: physical health checks

    Across 783 severe mental illness register patients, annual blood pressure checks fell 1.1 pp to 77.8% over 2023 to 2025 (England +4.4 pp to 83.4%) and BMI recording fell 0.7 pp to 77.6% (England +5.1 pp to 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    12,050

    Hypertension register

    +12.67%

    Register growth, 3 yrs

    Wigan (LAD) +10.59% · England +5.60%

    +5.65pp

    BP control, under 80

    ≤140/90 · +1.66pp aged 80+

    +3,554

    More patients by 2030

    Forecast 15,604 (23.93%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 18.9% (12,050 patients), above Wigan (LAD) (18.0%), England (15.2%) and NHS Greater Manchester Integrated Care Board (14.4%). Over 2023 to 2025, prevalence increased by +12.7% (England +5.6%, Wigan (LAD) +10.6%). Process and control indicators show: 91.5% had a recent blood pressure check (England 90.0%), and 77.1% were treated to target (England 70.3%). Among patients aged under 80, control reached 75.2% (England 67.8%), while in patients aged 80 and over it reached 85.7% (England 81.2%, Wigan (LAD) 86.4%). Crude rates do not account for age structure. Blood pressure control rates exceed national comparators across both age cohorts, though control in patients aged 80 and over remains 0.7 percentage points below Wigan (LAD).

    Lipids and statins

    Lipid therapy in patients with QRISK ≥ 20% is 62.4%, below Wigan (LAD) (64.0%), England (63.6%) and NHS Greater Manchester Integrated Care Board (67.0%), after a 3-year change of -0.7% over 2023 to 2025 (England +6.2%). Primary prevention lipid-lowering therapy trails all comparators following a three-year decline.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026126,962£1.90£1.94£1.86£241,228
    Cardiovascular (all), 2025178,751£3.88£3.15£3.33£693,554

    For lipid-modifying drugs in 2026, the PCN prescribed 126,962 items at £1.90 per item, below Wigan (£2.09) and the ICB (£1.94), but above England (£1.86), representing £5,078 more than at England's unit cost across 126,962 items. Unit spend is close to national and regional benchmarks, so clinical review of lipid therapy reach should take precedence over formulary unit-cost adjustments.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +2.28%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.30%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.8% (1,758 patients; England 1.9%, Wigan (LAD) 2.6%) following +11.2% growth over 2023 to 2025 (England +2.6%); 75.3% had an annual review (England 76.4%). Asthma prevalence is 7.2% (4,339 patients; England 6.6%) and annual review coverage is 61.9% (England 65.7%, Wigan (LAD) 64.4%), leaving an estimated scale of 1,653 unreviewed patients. In ages 5-19, asthma prescribing is 2,521 per 1,000 (England 1,488), while second-hand smoke recording in ages 6-19 is 67.2% (England 78.8%).

    Cancer register and children's immunisation

    The cancer register includes 2,626 patients (4.1% prevalence; England 3.8%). In Q1 2025/26 childhood immunisations, Wigan Central PCN exceeds national uptake across routine vaccines, including 6-in-1 at 24 months (96.3% vs England 92.2%) and MMR dose 1 at age 5 (96.5% vs England 91.7%). However, MMR dose 2 (90.1%) and 4-in-1 booster (90.1%) remain 4.9 pp below the 95.0% target.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.1%

    England 91.0%

    6-in-1 complete primary course at 24 months96.3%

    England 92.2%

    MMR dose 1 at 24 months96.3%

    England 88.3%

    MMR dose 2 at age 590.1%

    England 82.8%

    4-in-1 pre-school booster at age 590.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2 across NHS Greater Manchester ICB, compared to 55.3% in England and the 75.0% national ambition. Known-stage cancers represented 70.8% of 16,492 registered cases. Locally, Wigan Central PCN cervical screening coverage is 68.9% (Wigan 73.0%, England 66.8%), with Sullivan Way Surgery at 61.7% and Pemberton Surgery at 66.6%. ICB staging data reflects system presentation rather than PCN performance, but lower screening uptake could delay detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, the 62-day referral to treatment standard was 8.2 pp below the 85.0% operational standard, while 31-day combined treatment was 7.0 pp below its 96.0% standard. Conversely, 28-day faster diagnosis exceeded the 75.0% standard by 7.8 pp. Across NHS Greater Manchester Integrated Care Board, 28-day faster diagnosis was 4.5 pp above the 75.0% standard, while 62-day waits trailed the 85.0% standard. These figures describe acute trust and system performance rather than PCN delivery.

    Pathways within standard (%)Wrightington, Wigan and LeighMersey and West LancashireLancashireGreater Manchester ICBEngland
    28-day faster diagnosis (75%)82.8072.3982.9079.5379.32
    31-day treatment (96%)89.0495.4689.4396.4992.50
    62-day referral to treatment (85%)76.7877.9675.0475.7371.16
    Diagnostic waits over 6 weeks (%)Wrightington, Wigan and LeighMersey and West LancashireLancashireEngland
    MRI0.4914.042.4121.40
    CT7.7813.0814.979.92
    Echocardiography24.3734.8813.8528.48
    Colonoscopy6.1018.040.0030.83
    Gastroscopy12.5418.170.0029.02
    All 15 DM01 tests14.3621.1726.6523.14
    Community services activityWigan residentsGreater Manchester ICB
    Care contacts48,150573,310
    Referrals13,75094,470
    Patients with a contact18,695183,535

    Community services (residents of Wigan), Jun 2026 (provisional). In community health services, contacts with adults aged 65 and over represented 58.5% of all borough residents' contacts (28,190 of 48,150 contacts in Jun 2026 (provisional) data). These community services figures describe borough-level resident activity rather than PCN performance.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 42.4 percentage points and vaccination achievement varies by 30.1 percentage points

    For 2025/26, QOF clinical-domain achievement is 100.0% at Bradshaw Medical Centre and 97.7% at Newtown Medical Practice, compared to England at 97.1%. QOF vaccination and immunisation-domain achievement spans 30.1 pp across captured practices, from 50.1% at Bradshaw Medical Centre to 80.2% at Pemberton Surgery, against an England figure of 55.2%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Pemberton Surgery9156.080.3%70.9%97.3%
    Mesnes View11916.995.1%81.4%95.8%
    Dr Seabrook11311.488.2%57.4%94.7%
    Newtown Medical10452.584.1%71.3%92.5%
    Dicconson9442.572.5%63.7%89.6%
    Sullivan Way9041.565.2%57.5%84.2%
    Marsh Green10486.476.9%73.4%83.6%
    Longshoot Medical12342.456.8%64.0%79.3%
    Bradshaw11028.652.7%76.0%75.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWigan (LAD)AssetPCNWigan (LAD)
    Care homes (catchment)24 (891 beds)n/aSchools (catchment)81n/a
    Children's centres620Places of worship61164
    Libraries310Primary schools (LA maintained)1868
    Primary academies821Special schools13

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and smoke recording

    Asthma annual review coverage is 61.9% (Wigan (LAD) 64.4%, ICB 66.2%, England 65.7%) across 4,339 patients, an estimated scale of 1,653 unreviewed patients. For discussion, the PCN could run single-template asthma recall offering after-school slots, reviewing inhaler prescribing and recording second-hand smoke exposure. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Combined severe mental illness health checks

    On the 783-patient SMI register, annual BP checks are 77.8% (Wigan (LAD) 84.1%, England 83.4%), falling 1.1 pp over 2023 to 2025 (England +4.4 pp), and BMI recording is 77.6% (England 82.1%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Pharmacist-led lipid therapy recall review

    Lipid-lowering therapy in patients with QRISK ≥ 20% is 62.4% (Wigan (LAD) 64.0%, ICB 67.0%, England 63.6%), falling 0.7% (0.4 pp) over 2023 to 2025 (England +6.2%, +3.8 pp). Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    RecommendationIndicator(s)Policy anchorData level
    Care home visiting alignment (p2)Count of care home beds in PCN catchmentFit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework: revenue finance and contracting guidance 2026PCN
    Two-track Core20 resource allocation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Severe mental illness health checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Older patient blood pressure audit (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool immunisation call and recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma review and smoke recording (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Combined severe mental illness health checks (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Option 3 · Pharmacist-led lipid therapy recall review (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs) · Items prescribed per 1,000: Lipid-regulating drugs (18+, persons, 2026)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15